DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Kaletra (Lopinavir / Ritonavir) - Anaemia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Anaemia (49)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Kaletra (Lopinavir / Ritonavir) where reactions include anaemia. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 49   Next >>

Possible Kaletra side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-21

Patient:

Reactions: Atrial Septal Defect, Jaundice, Cardiac Murmur, Dysmorphism, Premature Baby, Foetal Exposure During Pregnancy, Anaemia, Ascites, Hydrops Foetalis, Talipes

Drug(s) suspected as cause:
Combivir
    Indication: Maternal Exposure Timing Unspecified

Kaletra
    Indication: Maternal Exposure Timing Unspecified



Possible Kaletra side effects in female

Reported by a physician from Russian Federation on 2012-08-17

Patient: female

Reactions: Umbilical Cord Abnormality, Anaemia, Placental Disorder, PRE-Eclampsia, Enterocolitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Epivir
    Indication: Product Used FOR Unknown Indication

Kaletra
    Indication: HIV Infection
    Start date: 2012-02-17

Kaletra

Nikavir
    Indication: HIV Infection

Other drugs received by patient: Valcit; Elevit; Folic Acid; Kipferon; Erythromycin; Combivir; Wobenzym; Hexicon Suppositories; Trichopol; Acyclovir



Possible Kaletra side effects in male

Reported by a physician from France on 2012-08-16

Patient: male

Reactions: Agitation, Urinary Incontinence, Coma, Coma Scale Abnormal, Pyrexia, Hepatotoxicity, Eye Movement Disorder, Hepatosplenomegaly, Anaemia, Malnutrition, General Physical Health Deterioration, Encephalopathy, Faecal Incontinence, Convulsion, Respiratory Tract Congestion, Apathy, Depressed Level of Consciousness, Nervous System Disorder, Confusional State, Immune Reconstitution Syndrome, Snoring, Hepatitis Cholestatic, Intracranial Pressure Increased, Hepatic Ischaemia, Thrombocytopenia, Oxygen Saturation Decreased, Refusal of Treatment by Patient, Necrotising Granulomatous Lymphadenitis, Hepatic Fibrosis, Mycobacterial Infection, Hyponatraemia, Cerebral Atrophy, White Blood Cell Disorder, Renal Failure, Hypoproteinaemia, Diarrhoea, Brain Abscess, Heart Rate Increased, Encephalitic Infection, Heart Sounds Abnormal

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Acetaminophen
    Dosage: df 10mg/ml
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10
    End date: 2012-07-16

Amikacin
    Dosage: 900 mg daily
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-11

Bactrim
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10
    End date: 2012-07-16

Cernevit-12
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10
    End date: 2012-07-16

Clarithromycin
    Dosage: df 50mg/ml
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-11

Folic Acid
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10
    End date: 2012-07-16

Isentress
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-05-01

Kaletra
    Dosage: df 80/20 mg
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-03-01

Myambutol
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-11

Nefopam
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10
    End date: 2012-07-16

Olanzapine
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-01

Perikabiven (Parenteral Nutrition)
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10
    End date: 2012-07-16

Potassium Chloride
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10
    End date: 2012-07-16

Prazepam
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10
    End date: 2012-07-16

Rifabutin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-11

Truvada
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-03-01

Viramune
    Indication: HIV Infection
    Start date: 2012-03-01
    End date: 2012-05-01

Other drugs received by patient: Propofol; Adavat



Possible Kaletra side effects in male

Reported by a physician from France on 2012-08-15

Patient: male

Reactions: Agitation, Urinary Incontinence, Coma, Pyrexia, Coma Scale Abnormal, Hepatotoxicity, Eye Movement Disorder, Hepatosplenomegaly, Anaemia, Malnutrition, Encephalopathy, Faecal Incontinence, General Physical Health Deterioration, Convulsion, Apathy, Respiratory Tract Congestion, Depressed Level of Consciousness, Nervous System Disorder, Confusional State, Immune Reconstitution Syndrome, Snoring, Hepatitis Cholestatic, Intracranial Pressure Increased, Hepatic Ischaemia, Thrombocytopenia, Oxygen Saturation Decreased, Refusal of Treatment by Patient, Necrotising Granulomatous Lymphadenitis, Hepatic Fibrosis, Mycobacterial Infection, Cerebral Atrophy, Hyponatraemia, Renal Failure, White Blood Cell Disorder, Diarrhoea, Hypoproteinaemia, Heart Rate Increased, Brain Abscess, Encephalitic Infection, Heart Sounds Abnormal

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Acetaminophen
    Dosage: df 10mg/ml
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10

Amikacin
    Dosage: 900 mg daily
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-11

Bactrim
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10

Cernevit-12
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10
    End date: 2012-07-16

Clarithromycin
    Dosage: df 50mg/ml
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-11

Folic Acid
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10

Isentress
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-05-01

Kaletra
    Dosage: df 80/20 mg
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-03-01

Myambutol
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-11

Nefopam
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10
    End date: 2012-07-16

Olanzapine
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-01

Perikabiven (Parenteral Nutrition)
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10

Potassium Chloride
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10

Prazepam
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10

Rifabutin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-11

Truvada
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-03-01

Viramune
    Indication: HIV Infection
    Start date: 2012-03-01
    End date: 2012-05-01

Other drugs received by patient: Adavat; Propofol



Possible Kaletra side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-13

Patient: male

Reactions: Confusional State, Agitation, Refusal of Treatment by Patient, Malnutrition, Anaemia, Coma, General Physical Health Deterioration, Pyrexia, Convulsion, Apathy, Hepatotoxicity, Diarrhoea, Thrombocytopenia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Acetaminophen
    Dosage: unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-11

Acupan
    Dosage: 120 mg, unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-16
    End date: 2012-07-27

Amikacin
    Dosage: 900 mg, unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-11

Bactrim
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-13

Cernevit / 01027001 /
    Dosage: unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10
    End date: 2012-08-02

Clarithromycin
    Dosage: 500 mg, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-11

Isentress
    Dosage: unk
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-05-01

Kaletra
    Dosage: unk
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-03-01

Leucovorin Calcium
    Dosage: unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10

Myambutol
    Dosage: 2 df, qd
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-11

Olanzapine
    Dosage: 1 df, unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-01

Perikabiven
    Dosage: unk
    Indication: Parenteral Nutrition
    Start date: 2012-07-10

Potassium Chloride
    Dosage: unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10

Prazepam
    Dosage: 1 df, qd
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-10

Rifabutin
    Dosage: 150 mg, unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-07-11

Truvada
    Dosage: unk
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2012-03-01



Possible Kaletra side effects in 41 year old female

Reported by a physician from Thailand on 2012-08-13

Patient: 41 year old female

Reactions: Anaemia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Lamivudine; Zidovudine



Possible Kaletra side effects in male

Reported by a physician from France on 2012-08-02

Patient: male, weighing 4.7 kg (10.3 pounds)

Reactions: Hypothermia, Foetal Exposure During Pregnancy, Anaemia, Tachycardia, Lactic Acidosis, Foetal Distress Syndrome, Apparent Death, Electroencephalogram Abnormal, Renal Failure, Rash Erythematous, Thrombocytopenia, Leukopenia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Abacavir Sulfate / Lamivudine
    Indication: Prophylaxis
    Start date: 2011-01-01
    End date: 2012-06-26

Kaletra
    Indication: Prophylaxis
    Start date: 2011-01-01
    End date: 2012-06-26

Retrovir
    Start date: 2012-06-26
    End date: 2012-06-29

Retrovir
    Indication: Prophylaxis
    Start date: 2012-06-26
    End date: 2012-06-26



Possible Kaletra side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-31

Patient:

Reactions: Jaundice, Atrial Septal Defect, Cardiac Murmur, Dysmorphism, Premature Baby, Anaemia, Foetal Exposure During Pregnancy, Limb Malformation, Ascites, Hydrops Foetalis, Talipes

Drug(s) suspected as cause:
Combivir
    Indication: Maternal Exposure Timing Unspecified

Kaletra
    Indication: Maternal Exposure Timing Unspecified



Possible Kaletra side effects in

Reported by a consumer/non-health professional from France on 2012-07-30

Patient:

Reactions: Drug Eruption, Death, Aspartate Aminotransferase Increased, Anaemia, Neutropenia, Leukopenia

Adverse event resulted in: death

Drug(s) suspected as cause:
Dapsone
    Dosage: 100 mg, qd
    Indication: Prophylaxis
    Start date: 2011-01-15

Epivir
    Dosage: 300 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-06-30

Isentress
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-05-30
    End date: 2010-08-31

Isoniazid
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Tuberculosis
    Start date: 2010-05-22
    End date: 2010-08-10

Kaletra
    Dosage: 20
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-11-22

Pyrazinamide
    Dosage: 2 g, qd
    Administration route: Oral
    Indication: Tuberculosis
    Start date: 2010-05-22
    End date: 2010-07-26

Rifampin
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Tuberculosis
    Start date: 2010-05-22
    End date: 2010-08-10

Viread
    Dosage: 300 mg, qd
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-05-30

Other drugs received by patient: Bactrim; Leucovorin Calcium; Leucovorin Calcium; Ivermectin; Acyclovir; Ciproflaxacin; Azithromycin; Pyridoxine HCL; Omeprazole



Possible Kaletra side effects in male

Reported by a physician from France on 2012-07-27

Patient: male

Reactions: Foetal Exposure During Pregnancy, Anaemia, Lactic Acidosis, Ill-Defined Disorder, Hepatic Enzyme Increased, Apparent Death, Foetal Distress Syndrome, Renal Failure, C-Reactive Protein Increased, Thrombocytopenia, Leukopenia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Abacavir Sulfate / Lamivudine
    Indication: Maternal Exposure Timing Unspecified

Kaletra
    Indication: Maternal Exposure Timing Unspecified

Retrovir
    Indication: Prophylaxis Against HIV Infection
    Start date: 2012-06-26
    End date: 2012-06-26

Retrovir
    Indication: Maternal Exposure Timing Unspecified



Possible Kaletra side effects in male

Reported by a physician from France on 2012-07-20

Patient: male

Reactions: Foetal Exposure During Pregnancy, Anaemia, Lactic Acidosis, Ill-Defined Disorder, Hepatic Enzyme Increased, Apparent Death, Foetal Distress Syndrome, Renal Failure, C-Reactive Protein Increased, Thrombocytopenia, Leukopenia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Abacavir Sulfate / Lamivudine
    Indication: Maternal Exposure Timing Unspecified

Kaletra
    Indication: Maternal Exposure Timing Unspecified

Retrovir
    Indication: Prophylaxis Against HIV Infection
    Start date: 2012-06-26
    End date: 2012-06-26

Retrovir
    Indication: Maternal Exposure Timing Unspecified



Possible Kaletra side effects in male

Reported by a physician from France on 2012-07-17

Patient: male, weighing 4.7 kg (10.3 pounds)

Reactions: Hypothermia, Tachycardia, Foetal Exposure During Pregnancy, Anaemia, Lactic Acidosis, Electroencephalogram Abnormal, Foetal Distress Syndrome, Apparent Death, Renal Failure, Rash Erythematous, Thrombocytopenia, Leukopenia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Abacavir Sulfate / Lamivudine
    Indication: Prophylaxis
    Start date: 2011-01-01
    End date: 2012-06-26

Kaletra
    Indication: Prophylaxis
    Start date: 2011-01-01
    End date: 2012-06-26

Retrovir
    Start date: 2012-06-26
    End date: 2012-06-29

Retrovir
    Indication: Prophylaxis
    Start date: 2012-06-26
    End date: 2012-06-26



Possible Kaletra side effects in male

Reported by a physician from France on 2012-07-16

Patient: male

Reactions: Anaemia, Foetal Exposure During Pregnancy, Lactic Acidosis, Ill-Defined Disorder, Hepatic Enzyme Increased, Foetal Distress Syndrome, Apparent Death, Renal Failure, C-Reactive Protein Increased, Thrombocytopenia, Leukopenia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Abacavir Sulfate / Lamivudine
    Indication: Maternal Exposure Timing Unspecified

Kaletra
    Indication: Maternal Exposure Timing Unspecified

Retrovir
    Indication: Maternal Exposure Timing Unspecified

Retrovir
    Indication: Prophylaxis Against HIV Infection
    Start date: 2012-06-26
    End date: 2012-06-26



Possible Kaletra side effects in female

Reported by a consumer/non-health professional from Brazil on 2012-07-05

Patient: female, weighing 53.0 kg (116.6 pounds)

Reactions: Weight Decreased, Vomiting, Nausea, Anaemia, Somnolence, Dengue Fever, Laziness, Fatigue, Ocular Icterus, Asthenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Unspecified Vitamin; Ferrous Sulfate TAB



Possible Kaletra side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-28

Patient:

Reactions: Atrial Septal Defect, Jaundice, Cardiac Murmur, Dysmorphism, Premature Baby, Foetal Exposure During Pregnancy, Anaemia, Limb Malformation, Ascites, Hydrops Foetalis, Talipes

Drug(s) suspected as cause:
Combivir
    Indication: Maternal Exposure Timing Unspecified

Kaletra
    Indication: Maternal Exposure Timing Unspecified



Possible Kaletra side effects in male

Reported by a pharmacist from United States on 2012-06-26

Patient: male, weighing 2.1 kg (4.6 pounds)

Reactions: Ventricular Hypokinesia, Premature Baby, Hyperkalaemia, Colitis Ulcerative, Anaemia, Maternal Exposure During Pregnancy, General Physical Health Deterioration, Toxicity To Various Agents, Cardiac Failure, Electrocardiogram Abnormal, Hypotonia, Abdominal Distension, Bradycardia, Sinoatrial Block, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Combivir
    Indication: Maternal Exposure Timing Unspecified

Kaletra
    Indication: Maternal Exposure Timing Unspecified

Kaletra
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2007-05-26
    End date: 2007-05-30

Saquinavir
    Indication: Maternal Exposure Timing Unspecified



Possible Kaletra side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-20

Patient:

Reactions: Jaundice, Atrial Septal Defect, Cardiac Murmur, Dysmorphism, Premature Baby, Foetal Exposure During Pregnancy, Anaemia, Limb Malformation, Ascites, Hydrops Foetalis, Talipes

Drug(s) suspected as cause:
Combivir
    Indication: Maternal Exposure Timing Unspecified

Kaletra
    Indication: Maternal Exposure Timing Unspecified



Possible Kaletra side effects in female

Reported by a physician from Japan on 2012-06-08

Patient: female

Reactions: Caesarean Section, Maternal Exposure During Pregnancy, Anaemia, Delivery

Drug(s) suspected as cause:
Combivir
    Dosage: 2iuax per day
    Administration route: Oral
    Start date: 2011-11-10

Combivir
    Dosage: 2iuax per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-09-22
    End date: 2011-09-28

Epivir
    Dosage: 2iuax per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-09-29
    End date: 2011-11-09

Kaletra
    Dosage: 4iuax per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-09-22

Retrovir
    Dosage: 4iuax per day
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2011-09-29
    End date: 2011-11-09



Possible Kaletra side effects in female

Reported by a physician from Botswana on 2012-06-01

Patient: female

Reactions: Anaemia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Lamivudine + Zidovudine



Possible Kaletra side effects in 27 year old female

Reported by a physician from Japan on 2012-05-30

Patient: 27 year old female

Reactions: Anaemia, Alanine Aminotransferase Increased, Maternal Exposure During Pregnancy, Aspartate Aminotransferase Increased

Drug(s) suspected as cause:
Kaletra
    Dosage: 4tab per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2011-03-22

Lamivudine (Epivir Hbv)
    Indication: Antiretroviral Therapy
    Start date: 2011-12-22

Norvir
    Dosage: 100mgd per day
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-06

Retrovir
    Indication: Antiretroviral Therapy
    Start date: 2011-12-22

Reyataz
    Administration route: Oral
    Indication: Antiretroviral Therapy
    Start date: 2012-03-06

Truvada
    Indication: Antiretroviral Therapy
    Start date: 2012-02-28



Possible Kaletra side effects in 65 year old male

Reported by a physician from Korea, Republic of on 2012-05-29

Patient: 65 year old male

Reactions: White Blood Cell Count Decreased, Pneumonia, Anaemia, Hepatic Failure, Haemoglobin Decreased, Renal Failure, Diarrhoea, Sepsis, Dizziness, Bone Marrow Failure, Diarrhoea Infectious, Leukopenia, Decreased Appetite

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Azt(zdv); Megace Suspension 40mg / 240ml; CJ 20% Dextrose Water 0.2g / ML 1000ml; ABC; TS TAB; Cebatrim INJ; Dapsone; Ziagen; Norpine; Combivir; Lamivudine (Epivir Hbv)



Possible Kaletra side effects in female

Reported by a physician from Guinea-Bissau on 2012-04-17

Patient: female

Reactions: Anaemia, Pyrexia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Lamivudine; Abacavir; Cotrim; Folic Acid



Possible Kaletra side effects in female

Reported by a physician from Guinea-Bissau on 2012-04-16

Patient: female

Reactions: Anaemia, Pyrexia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Cotrim; Folic Acid; Abacavir; Lamivudine



Possible Kaletra side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-13

Patient: male, weighing 64.9 kg (142.8 pounds)

Reactions: Vomiting, Nausea, Anaemia, Rectal Haemorrhage, Drug Interaction, Cushing's Syndrome, Blood Potassium Decreased, Oedema Peripheral, Compression Fracture, Thoracic Vertebral Fracture

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient possibly interacting with the suspect drug:
Triamcinolone
    Indication: Compression Fracture
    Start date: 2012-01-01
    End date: 2012-01-01



Possible Kaletra side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-12

Patient:

Reactions: Jaundice, Atrial Septal Defect, Cardiac Murmur, Dysmorphism, Premature Baby, Anaemia, Foetal Exposure During Pregnancy, Limb Malformation, Ascites, Hydrops Foetalis, Talipes

Drug(s) suspected as cause:
Combivir
    Indication: Maternal Exposure Timing Unspecified

Kaletra
    Indication: Maternal Exposure Timing Unspecified



Possible Kaletra side effects in 65 year old male

Reported by a physician from Korea, Republic of on 2012-04-09

Patient: 65 year old male

Reactions: White Blood Cell Count Decreased, Pneumonia, Anaemia, Hepatic Failure, Haemoglobin Decreased, Renal Failure, Diarrhoea, Sepsis, Bone Marrow Failure, Diarrhoea Infectious, Leukopenia, Decreased Appetite

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Kaletra

Other drugs received by patient: Norpine; TS TAB; ABC; Dapsone; Combivir; Cebatrim INJ; Lamivudine (Epivir Hbv); Megace Suspension 40mg / 240ml; Azt(zdv); CJ 20% Dextrose Water 0.2g / ML 1000ml; Ziagen



Possible Kaletra side effects in 35 year old female

Reported by a physician from Korea, Republic of on 2012-03-30

Patient: 35 year old female, weighing 55.0 kg (121.0 pounds)

Reactions: Vomiting, Nausea, Anaemia, Premature Labour, Vaginal Haemorrhage

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kaletra
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2010-09-16
    End date: 2011-03-21

Kaletra
    Administration route: Oral
    Start date: 2010-04-07
    End date: 2010-09-05

Kaletra
    Administration route: Oral
    Start date: 2010-09-06
    End date: 2010-09-15

Other drugs received by patient: Abacavir; Methylergometrine Maleate; Aceclofenac; Lamivudine (Epivir Hbv); Methylergometrine Maleate; Oxytocin 5IU; Magnesium Hydroxide TAB; Combivir; Ranitidine; Cefminox



Possible Kaletra side effects in 51 year old female

Reported by a physician from Spain on 2012-03-22

Patient: 51 year old female

Reactions: Anaemia, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kaletra
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-01-01

Pegasys
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-09-28
    End date: 2012-02-07

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-09-28
    End date: 2012-02-07

Truvada
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-01-01
    End date: 2012-02-07



Possible Kaletra side effects in 51 year old female

Reported by a physician from Spain on 2012-03-22

Patient: 51 year old female

Reactions: Drug Ineffective, Anaemia, Haemolytic Anaemia, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kaletra
    Dosage: 200mg/50mg
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-01-01

Peginterferon Alfa-2A
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-09-28
    End date: 2012-02-07

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-09-28
    End date: 2012-02-07

Truvada
    Dosage: 200mg/245mg
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-01-01
    End date: 2012-02-07



Possible Kaletra side effects in 51 year old female

Reported by a physician from Spain on 2012-03-20

Patient: 51 year old female

Reactions: Anaemia, Renal Failure Acute

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Kaletra
    Dosage: 1 df, unk
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-01-01

Pegasys
    Start date: 2011-09-28
    End date: 2012-02-07

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-09-28
    End date: 2012-02-07

Truvada
    Dosage: 1 df, unk
    Administration route: Oral
    Indication: HIV Infection
    Start date: 2008-01-01
    End date: 2012-02-07



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014